Your browser doesn't support javascript.
loading
Fibrillin-1 and asprosin, novel players in metabolic syndrome.
Summers, Kim M; Bush, Stephen J; Davis, Margaret R; Hume, David A; Keshvari, Sahar; West, Jennifer A.
Affiliation
  • Summers KM; Mater Research Institute-University of Queensland, Translational Research Institute, 37 Kent St, Woolloongabba, Queensland 4102, Australia. Electronic address: kim.summers@mater.uq.edu.au.
  • Bush SJ; Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Headley Way, Oxford OX3 9DS, United Kingdom. Electronic address: stephen.bush@ndcls.ox.ac.uk.
  • Davis MR; The Roslin Institute, University of Edinburgh, Easter Bush, Midlothian EH25 9RG, United Kingdom.
  • Hume DA; Mater Research Institute-University of Queensland, Translational Research Institute, 37 Kent St, Woolloongabba, Queensland 4102, Australia. Electronic address: david.hume@uq.edu.au.
  • Keshvari S; Mater Research Institute-University of Queensland, Translational Research Institute, 37 Kent St, Woolloongabba, Queensland 4102, Australia. Electronic address: s.keshvari@uq.edu.au.
  • West JA; Faculty of Medicine, The University of Queensland, Mayne Medical Building, 288 Herston Road, Herston, Queensland 4006, Australia. Electronic address: j.west@uq.edu.au.
Mol Genet Metab ; 138(1): 106979, 2023 01.
Article in En | MEDLINE | ID: mdl-36630758

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Metabolic Syndrome Limits: Humans Language: En Journal: Mol Genet Metab Journal subject: BIOLOGIA MOLECULAR / BIOQUIMICA / METABOLISMO Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Metabolic Syndrome Limits: Humans Language: En Journal: Mol Genet Metab Journal subject: BIOLOGIA MOLECULAR / BIOQUIMICA / METABOLISMO Year: 2023 Type: Article